Search research articles
Contact Us
Filters
Showing results (241-250 of 299) with videos related to
Page
of 30
Sort By:
International Journal of Cancer
|
May 17, 2017
Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival
Shun Liu, Yanru Wang, William Xue, et al.
The Journal of Clinical Investigation
|
April 9, 2019
USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells
Zhengxin Chen, Hong-Wei Wang, Shuai Wang, et al.
Neuro-Oncology
|
March 18, 2009
REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy
Huibo Wang, Shu-Yu Zhang, Shuai Wang, et al.
The Journal of Allergy and Clinical Immunology
|
March 18, 2020
Bcl6 and Blimp1 reciprocally regulate ST2<sup>+</sup> Treg-cell development in the context of allergic airway inflammation
Byunghee Koh, Benjamin J Ulrich, Andrew S Nelson, et al.
Nature Communications
|
March 7, 2026
Direct oxidative carbonylation of methane to acetic acid via high-valent iron-oxo mediated water activation
Haonan Zhang, Richard J Lewis, A Iulian Dugulan, et al.
BMJ Global Health
|
May 30, 2020
Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China
Yu Wang, Huaiyu Tian, Li Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2012
Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenografts
Gaspar J Kitange, Ann C Mladek, Brett L Carlson, et al.
Journal of Neuro-Oncology
|
November 18, 2008
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
Gaspar J Kitange, Brett L Carlson, Ann C Mladek, et al.
Molecular Cancer Therapeutics
|
January 29, 2009
Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines
Michelle J Clarke, Evan A Mulligan, Patrick T Grogan, et al.
Carcinogenesis
|
May 14, 2010
A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer
Shuyu Zhang, Juan Lu, Xueying Zhao, et al.
Page
of 30
Search research articles
Search
Showing results (241-250 of 299) with videos related to
Sort By:
Page
of 30
International Journal of Cancer
|
May 17, 2017
Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival
Shun Liu, Yanru Wang, William Xue, et al.
The Journal of Clinical Investigation
|
April 9, 2019
USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells
Zhengxin Chen, Hong-Wei Wang, Shuai Wang, et al.
Neuro-Oncology
|
March 18, 2009
REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy
Huibo Wang, Shu-Yu Zhang, Shuai Wang, et al.
The Journal of Allergy and Clinical Immunology
|
March 18, 2020
Bcl6 and Blimp1 reciprocally regulate ST2<sup>+</sup> Treg-cell development in the context of allergic airway inflammation
Byunghee Koh, Benjamin J Ulrich, Andrew S Nelson, et al.
Nature Communications
|
March 7, 2026
Direct oxidative carbonylation of methane to acetic acid via high-valent iron-oxo mediated water activation
Haonan Zhang, Richard J Lewis, A Iulian Dugulan, et al.
BMJ Global Health
|
May 30, 2020
Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China
Yu Wang, Huaiyu Tian, Li Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 8, 2012
Inhibition of histone deacetylation potentiates the evolution of acquired temozolomide resistance linked to MGMT upregulation in glioblastoma xenografts
Gaspar J Kitange, Ann C Mladek, Brett L Carlson, et al.
Journal of Neuro-Oncology
|
November 18, 2008
Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model
Gaspar J Kitange, Brett L Carlson, Ann C Mladek, et al.
Molecular Cancer Therapeutics
|
January 29, 2009
Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines
Michelle J Clarke, Evan A Mulligan, Patrick T Grogan, et al.
Carcinogenesis
|
May 14, 2010
A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer
Shuyu Zhang, Juan Lu, Xueying Zhao, et al.
Page
of 30